UNSPSC 51123104: Actisomide

This classification denotes an antiarrhythmic agent with the molecular formula C23H35N3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) IJQ29N87NR, chemically known as 3h-pyrido(1,2-c)pyrimidin-3-one, 4-(2-(bis(1-methylethyl)amino)ethyl)-4,4a,5,6,7,8-hexahydro-1-methyl-4-phenyl-, cis-(+-)- but more generally known as actisomide, which bears US NIH Compound Identifier 57147. European Medicines Agency schedules Actisomide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05257MIG.

UNSPSC 51123104 Actisomide, a Commodity code, covers pharmaceutical active pharmaceutical ingredients and finished medications procured by state and local health agencies, emergency services, and cooperative purchasing alliances for distribution through public health systems, emergency medical services, and state Medicaid programs. State and local governments buy this code as part of broader pharmaceutical supply contracts that bundle multiple medication line items, dosage forms, and delivery requirements into single procurements managed by city purchasing departments, state health commissions, and multistate cooperative purchasing vehicles. Issuing bodies span city fire rescue services (Tampa Fire Rescue through the City of Tampa), state health and human services departments (Texas HHS Commission), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, or MMCAP). Recent activity shows state and local procurement offices consolidating pharmaceutical purchases across multiple active pharmaceutical ingredients and finished products into unified solicitations rather than acquiring individual drugs in isolation.

Activity is concentrated in Florida, Texas, and Minnesota based on recent opportunities. The City of Tampa Purchasing Department issued an IFB (Bid No. 26-P-00188) posted April 24, 2026, with a response date of April 8, 2026, soliciting Advanced Life Support Medications including Labetalol HCI, Epinephrine, Adenosine, and Diltiazem for Tampa Fire Rescue with an estimated contract value of $40,000 and a one-year term plus optional renewals; the procurement included a 5 percent bid discount for Small Local Business Enterprise participation. The Minnesota Department of Administration, on behalf of MMCAP, issued an RFP (S1070000015802) due March 26, 2026, for generic multi-source pharmaceuticals and OTC products to be distributed through AmerisourceBergen Drug Corporation, Cardinal Health, and Morris & Dickson Co., LLC, with evaluation weighted 75 percent on price competitiveness and a two-year contract term. The Texas HHS Commission issued an RFI (HHS0017013) on April 3, 2026, to gather market intelligence on direct-to-manufacturer prescription programs, signaling early-stage procurement planning rather than immediate opportunity.